SE9902938D0 - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- SE9902938D0 SE9902938D0 SE9902938A SE9902938A SE9902938D0 SE 9902938 D0 SE9902938 D0 SE 9902938D0 SE 9902938 A SE9902938 A SE 9902938A SE 9902938 A SE9902938 A SE 9902938A SE 9902938 D0 SE9902938 D0 SE 9902938D0
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutical compositions
- active ingredient
- propylsulphonyl
- nedocromil
- phenylethoxy
- Prior art date
Links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a pharmaceutical composition, pharmaceutical product or kit comprising a first active ingredient (A) being 4-hydroxy-7-[2-[2-[3-[2-phenylethoxy]propylsulphonyl]ethylamino]ethyl]-1,3-benzothiazol-2(3<i>H</i>)-one or a pharmaceutically acceptable salt thereof, and a second active ingredient (B) being disodium cromoglycate or nedocromil, for use in the treatment of obstructive airways diseases.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9902938A SE9902938D0 (en) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
PCT/GB2000/003116 WO2001012192A2 (en) | 1999-08-18 | 2000-08-14 | Pharmaceutical compositions comprising a-(2-aminoethyl)-benzothiazolone and disodium cromoglycate or nedocromil |
AU64603/00A AU6460300A (en) | 1999-08-18 | 2000-08-14 | Pharmaceutical compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9902938A SE9902938D0 (en) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9902938D0 true SE9902938D0 (en) | 1999-08-18 |
Family
ID=20416696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9902938A SE9902938D0 (en) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU6460300A (en) |
SE (1) | SE9902938D0 (en) |
WO (1) | WO2001012192A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE435855T1 (en) | 2003-11-21 | 2009-07-15 | Theravance Inc | COMPOUNDS HAVING AGONISTIC ACTION ON THE BETA2-ADRENERGIC RECEPTOR AND THE MUSCARINIC RECEPTOR |
TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
TW200745067A (en) | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
AU2009260899B2 (en) | 2008-06-18 | 2012-02-23 | Astrazeneca Ab | Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9211172D0 (en) * | 1992-05-27 | 1992-07-08 | Fisons Plc | Compounds |
-
1999
- 1999-08-18 SE SE9902938A patent/SE9902938D0/en unknown
-
2000
- 2000-08-14 WO PCT/GB2000/003116 patent/WO2001012192A2/en active Application Filing
- 2000-08-14 AU AU64603/00A patent/AU6460300A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU6460300A (en) | 2001-03-13 |
WO2001012192A3 (en) | 2001-12-13 |
WO2001012192A2 (en) | 2001-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20034612L (en) | 3,4-di-substituted cyclobutene-1,2-dione, pharmaceutical compositions comprising the compounds, and use of the compounds for the manufacture of medicaments for the treatment of chemokine-mediated diseases | |
WO2002085909A8 (en) | 9-deazaguanine derivatives as inhibitors of gsk-3 | |
ATE504579T1 (en) | ANTIVIRAL AGENTS | |
EA200301165A1 (en) | Drug on the basis of oxycodone | |
CY2013041I1 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | |
ATE248837T1 (en) | QUINUCLIDINE-ACRYLAMIDE | |
CA2396561A1 (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
GEP20053600B (en) | 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors | |
BR0210122A (en) | Compound or a pharmaceutically acceptable salt thereof, method for treating or preventing a disease, use of the compound or salt thereof, and method for preparing the same | |
HK1072181A1 (en) | Pharmaceutical compositions for the oral administration of heparin or derivatives thereof | |
ITFI20030058A1 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING THIAZOLIDINEDIONI | |
SE9902935D0 (en) | Pharmaceutical compositions | |
DE60035429D1 (en) | USE OF SULFODE HYDROABETIC ACIDS FOR THE TREATMENT OF INFLAMMATORY ENDURANCE | |
SE9902937D0 (en) | Pharmaceutical compositions | |
SE9902938D0 (en) | Pharmaceutical compositions | |
HUP9802897A2 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
SE9902936D0 (en) | Pharmaceutical compositions | |
HUP0402092A2 (en) | Use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts for preparation of pharmaceutical compositions | |
BR0011845A (en) | Pharmaceutical complex | |
HUP0402654A2 (en) | 2-[(2'-halo-3',5'-dialkoxyphenyl)-imino]-imidazolidine derivatives, use thereof and pharmaceutical compositions containing them | |
DE60108354D1 (en) | 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions | |
BR0213463A (en) | Macrolide-containing pharmaceutical compositions | |
FR2843301B1 (en) | GALENIC FORM FOR THE COLIC DELIVERY OF ACTIVE INGREDIENTS | |
WO2002036105A3 (en) | Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders | |
NO20043889L (en) | Pharmaceutical compositions comprising 2- (4-ethoxy-phenyl) -3- (4-methanesulfonyl-phenyl) -pyrazolo 1,5-bipyridazine in nanoparticle form |